Portfolio company
iPrenom
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This molecular diagnostics company develops blood tests to detect and predict pregnancy complications for expectant mothers and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NX Prenatal
This company develops exosome-based blood tests to detect pregnancy complications for physicians and expectant mothers.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Diagnoly
This company develops artificial intelligence software for prenatal ultrasound imaging to help healthcare professionals detect fetal abnormalities.
Genomic Prediction
The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.
gMendel
This company develops AI-powered software and diagnostic tests for prenatal and newborn genetic disorder screening for hospitals, laboratories and health ministries.
BillionToOne
This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.
LOVU
This company develops a remote patient monitoring platform that predicts and prevents pregnancy complications for expectant mothers and healthcare providers.
Aggamin
This biotechnology company develops an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins for pregnant women and healthcare providers.
